EUVIMED · CrossrefZeitschrift
Psychedelic Medicine
ISSN 2831-4425 · SAGE Publications
Neueste Artikel
The Effect of Psychedelics on Individuals with a Personality Disorder: Results from Two Prospective Cohort Studies
Ceremonial Psychedelic Experiences and Changes in Mental Health Outcomes in Those with Adverse Childhood Experiences
Effects of 5-HT 2A Receptor Activation on Oxycodone Demand after Short and Long Access Self-Administration in Male and Female Rats
A Practical Approach and Framework to Quality Management for Psychedelic Drug Development
Past-Year Lysergic Acid Diethylamide Use in United States Sexual Minorities from 2015 to 2019
Effects of Psychedelics Lysergic Acid Diethylamide and R (–)-2,5-Dimethoxy-4-Iodoamphetamine on Oral Opioid Consumption and Naloxone-Precipitated Withdrawal in Male C57Bl/6J Mice
A Pharmacological Basis for Some Bad LSD “Trips”?
Letter: Reconsidering Scopolamine as a Psychedelic Adjunct in Exposure-Based Therapy: Cholinergic Modulation and Fear Extinction in Social Anxiety Disorder
From Evidence to Practice: A Systematic Review of Implementation of Psychedelic-Assisted Psychotherapy
Behavioral Shifts in Natural Speech, Language, and Facial Expression Following Ayahuasca Ceremonies
Correlation of Ketamine and Classic Psychedelics with Pain-Related Neural Connectivity: A Scoping Review of Clinical Experiments on a Potential Therapeutic Target Concerning Ketamine and Classical Psychedelics Administration for Pain Relief
Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice—Lessons Learned from a State Underrepresented in Clinical Psychedelic Research
A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
Exploring Access to Psychedelics Among Canadian Veterans: Pathways, Barriers, and Perceptions
Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto Rats
Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study
Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study
Strong Alliance, Weak Conclusions: Comment on Goodwin et al. (2026) “The Role of Therapeutic Alliance in Psilocybin Treatment for Treatment-Resistant Depression”
Meaning-Centered Psychotherapy for Psilocybin-Assisted Therapy Among Patients with Advanced Cancer and Depression: Rationale and Preliminary Evaluation of MCP-PSIL
Who Keeps Using Lysergic Acid Diethylamide? Correlates of Past-Year Use in People Who Initiated Use at least Five Years Ago
“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group Therapy
Suggested Guidelines for Applying a Systemic Lens to Psychedelic-Assisted Psychotherapy
Psychedelics and Respiratory Health: A Literature Review
Advancing the Field of Psychedelic Epidemiology
US Institutional Review Board Perspectives Regarding Psychedelic Research
Dorsal Raphe Revisited: A Systems Neuroscience Lens on Psychedelic Drug Action
Therapeutic Effects of Low-Dose Psilocybin in Depression and Other Mental Disorders: A Systematic Review
Attitudes of U.S. Muslims Toward Psychedelics
Perceived Availability of Lysergic Acid Diethylamide in the United States from 2015 to 2019
Views on Psychedelic-Assisted Therapy for Substance Use Disorders from Individuals with Opioid Use Disorder and a History of Injection-Related Infections: A Qualitative Study
EUVIMED